|
Patricia Donahue is Vice President Collaborations Business. Pat has more than 25 years of biotechnology and pharmaceutical industry experience. As leader of the Collaborations Business she is responsible for the establishment and management of the antibody discovery and development collaborations XOMA conducts with other biotechnology and pharmaceutical companies. She also supports product licensing and strategic business initiatives. In 2004 Ms. Donahue joined the Company as Director Business Development where she established the architecture for XOMA’s HE(TM) technology and antibody collaborations businesses. Previously Pat held positions of increasing responsibility at Merck KGaA / EMD Dey Labs and 3M Pharmaceuticals where she demonstrated cross-functional leadership while holding functional responsibility in new molecule research clinical research marketing and sales program management and business to corporate development. While at 3M she was a key member of the core teams bringing Tambocor® and Climara® from late stage clinical development to approval. Ms. Donahue holds a B.A. in biology and chemistry from Gustavus Adolphus College St. Peter MN and an MBA from the University of St. Thomas St. Paul MN. | 